Citation

Molly Nozyce, Ph.D., Sophia S. Lee, M.S., Sophia S. Lee, M.S., Sharon Appelbaum Nachman, M.D., Andrew A. Wiznia, M.D., Sharon Appelbaum Nachman, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Mary Smith, R.N., Ram Yogev, M.D., Kenneth McIntosh, M.D., Kenneth Stanley, Ph.D., Stephen Ira Pelton, M.D. A behavioral and cognitive profile of clinically stable HIV-infected children. Pediatrics. 2006 Mar 10; 117(3):763-770.

Citation

Michelle Marcial, Jing Lu, M.S., Steven G. Deeks, M.D., Ranier Ziermann, Daniel R. Kuritzkes, M.D. Performance of human immunodeficiency virus type 1 gp41 assays for detecting enfuvirtide (T-20) resistance mutations. Journal of Clinical Microbiology. 2006 Sep 01; 44(9):3384-7.

Citation

David W. Haas, M.D. Human genetic variability and HIV treatment response. Current HIV/AIDS Reports. 2006 Jul 01; 3(2):53-8.

Citation

Yangxin Huang, Ph.D., Hulin Wu, Ph.D. A Bayesian approach for estimating antiviral efficacy in HIV dynamic models. Journal of Applied Statistics. 2006 Aug 19; 33(2):155-74.

Citation

Michael M. Lederman, M.D. Immune success and immune failure in HIV infection: implications for therapeutic intervention. Journal of Acquired Immune Deficiency Syndromes. 2006 Jul 01; 42(Suppl 1):S8-9.

Citation

joke Snoeck, Rami Kantor, M.D., Robert Shafer, M.D., Kristel Van Laethem, Koen Deforche, Ana Patricia Carvalho, Brian Wynhoven, Marcelo A. Soares, Patricia Cane, John Clarke, Candice Pillay, Sunee Sirivichayakul, Koyo Ariyoshi, Africa Holgiun, Hagit Rudich, Rosangela Rodrigues, Maria Belen Bouzas, Francoise Brun-Vezinet, Caroline Reid, Pedro E. Cahn, M.D., Luis Fernando Brigido, Zehava Grossman, Vincent Soriano, Wataru Sugiura, Praphan Phanuphak, M.D., Ph.D., Lynn Morris, Jonathan Weber, Deenan Pillay, Amilcar Tanuri, Richard Harrigan, Ricardo Camacho, Jonathan M. Schapiro, David Katzenstein, M.D., Anne-Mieke Vandamme. Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent. Antimicrobial Agents and Chemotherapy. 2006 Feb 01; 50(2):694-701.

Citation

Heather Ribaudo, Ph.D., David W. Haas, M.D., Camlin Tierney, Ph.D., Richard B. Kim, M.D., Grant R Wilkinson, Ph.D., D.Sc., Roy (Trip) Gulick, M.D., M.P.H., David B. Clifford, M.D., Catia Marzolini, Courtney V. Fletcher, Pharm.D., Karen T. Tashima, M.D., Daniel R. Kuritzkes, M.D., Edward P. Acosta, Pharm.D. Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an adult AIDS clinical trials group study. Clinical Infectious Diseases. 2006 Feb 01; 42(3):401-7.